chartexchange

IMTX
Immatics N.V.
stockNASDAQ

At CloseNov 18, 2026 3:59:56 PM EST
6.11USD-2.941%(-0.18)1,571,188
After-hoursNov 18, 2026 4:00:30 PM EST
6.10USD-0.082%(-0.01)
Loading…
Loading…
929.59M
Healthcare
Biotechnology
HQ
Tübingen, Baden Wuerttemberg, Germany
Previous Close
$6.29
Beta
1.46
52-Week High
$12.41 2025-12-04
52-Week Low
$5.95 2026-11-18
SMA 50
$7.52
SMA 200
$9.37
Avg. Vol 10D
1.21M
Avg. Vol 30D
1.18M
Avg. Vol 90D
807,481
Relative Vol
1.33
152.27M
127.72M
0.4000%
4,100,000
IMTX Profile

immatics is a clinical-stage biopharmaceutical company active in the discovery and development of t-cell redirecting immunotherapies for the treatment of cancer. our transformative product candidates are - best in class - adoptive cell therapies and bispecific tcr molecules. these products are directed against tumor targets that have been identified and validated by immatics'​ proprietary and world-leading xpresident® technology. our mission is to bring the power of t-cell redirecting immunotherapies to cancer patients. quick facts - 150 team members - >100 targets covering 20 major solid and liquid tumors - about 80% of discovered targets are novel - 2 proprietary technology platforms - 8 proprietary development programs, thereof 2 in the clinic in 2017 - multiple partnered programs - raised more than $230m in cash in five financings read more about immatics on our homepage: https://immatics.com/ find us on twitter and xing: twitter: http://bit.ly/2dfbpre xing: http://bit.ly/2e1kkpv l

IMTX Performance
PeriodPriceDateChangeBeta
1W6.522026-11-12-6.37%0.239
1M7.052026-10-19-13.40%1.663
3M9.252026-08-19-34.00%1.549
6M10.702026-05-19-42.94%1.228
1Y10.332025-11-19-40.90%1.456
2Y7.812024-11-19-21.83%—
5Y11.892021-11-19-48.65%1.050
IMTX Stock Summary

Immatics N.V. (NASDAQ:IMTX) stock price today is $6.11, and today's volume is 1,571,188. IMTX is down 2.941% today. The 30 day average volume is 1.18M. IMTX market cap is $929.59M with 152.27M shares outstanding.